期刊文献+

^(18)F-FDG PET-CT在卵巢癌术后监测中的应用 被引量:4

Role of positron emission tomographic-CT in monitoring treatment of ovarian carcinoma
下载PDF
导出
摘要 目的:探讨18氟-脱氧葡萄糖(18F-FDG)正电子发射计算机体层摄影(PET-CT)在卵巢癌术后监测中的应用价值。方法:16例卵巢癌患者经肿瘤细胞减灭术和术后化疗或放疗,临床完全缓解6个月以上。行18F-FDG PET-CT检查,结果与手术病理结果对照。结果:18F-FDG PET-CT发现了9例患者,有复发或转移,共发现病灶直径0.3~3.2cm 23处病灶。手术病理证实9例(56%)无假阳性,无假阴性,诊断准确率100%;诊断复发或转移灶的敏感性、特异性、准确率、阳性预测值和阴性预测值分别为78%、78%、78%、90%和58%。PET-CT显示与术中所见病灶的大小、部位均一致。结论:18F-FDGPET-CT在卵巢癌的术后监测中有很高的诊断价值。 Objective:To investigate the efficiency of ^18 F fluoro-2-deoxy-glueose(^18F-FDG) positron emission tornographie-CT for detecting recurrent ovarian carcinoma.Methods:Sixteen women with ovarian carcinoma treated with primary cytoreductive surgery and followed up with chemotherapy or radiotherapy underwent fluorodeoxyglucese(^18F-FDG) PET-CT and compared with surgical pathology after surgical second-look to determine the diagnostic accuracy of PET-CT in the evaluation of disease status.Results:Nine (56%) of 16 patients had persistent tumor at histologic analysis after surgical second-look, and seven (44%) had no histologically proved tumor. The total that was positive for tumor cells at histologic analysis was 23 lesions; maximum diameter of these lesions was 0.3 - 3.2cm. ^18 F-FDG PET-CT found all 9 patients with persistent tumor successfully. The overall lesion-based sensitivity, specificity, accuracy, positive predictive value and negative predictive value of ^18 F-FDG PET-CT were 78% ,78% ,78% ,90% and 90%. ^18 F-FDG PET-CT imaging findings consistent with surgical second-look in the size and site of tumor. Conclusion:^18F-FDG PET-CT has high value for monitoring and locating the recurrence of ovarian carcinoma.
出处 《医学影像学杂志》 2006年第4期370-373,共4页 Journal of Medical Imaging
基金 山东省医药卫生科技发展计划(2005HW093)
关键词 卵巢肿瘤 体层摄影术 发射型计算机 X线计算机 Ovarian neoplasm Tomography, emission-computed Tomography, X-ray Computed
  • 相关文献

参考文献7

  • 1Sironi S,Messa C,Mangili G,et al.Integrated FDG PET/CT in patients with persistent ovarian cancer:correlation with histologic findings [J].Radiology,2004,233:433-440.
  • 2Bristow RE, del Carmen MG,Pannu HK,et al.Clinically occult recurrent ovarian cancer:patient selection for secondary cytoreductive surgery using combine PET/CT[J].Gynecol Oncol,2003,90:519-528.
  • 3Herbst AL.The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease[J].Am J Obstet Gynecol,1994,170:1099-1105.
  • 4Kubik-Huch RA,Drffler W,von Schulthess GK,et al.Value of(^18F)-FDG positron emission tomography,computed tomography,and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma[J].Eur Radiol,2000,10:761-767.
  • 5Nanni C,Rubello D,Farsad M,et al.^18F-FDG PET/CT in the evaluation of recurrent ovarian cancer:a prospective study on forty-one patients[J].Eur J Surg Oncol,2005,31:792-797.
  • 6Subhas N,Patel PV,Jacene HA, et al.Imaging of pelvic malignancies with in-line FDG PET-CT:case example and common pitfalls of FDG PET[J].Radiographics,2005,25:1031-1043.
  • 7Ogawa M,Ishino S,Mukai T,et al.^18F-FDG accumulation in atherosclerotic plaques:immunohistochemical and PET imaging study [J].J Nucl Med,2004,45:1245-1250.

同被引文献22

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部